Providing Better Patient Care
Westgate Las Vegas Resort & Casino Recorded: June 2-4, 2026
About This Course
This course provides 15 contact hours of pharmacy CE and (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.
Recorded in Las Vegas Nevada on June 2-4, 2026
Price $250 for 15 Hours
Learning Objectives
-
Apply recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension and dyslipidemia
2. Review lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease
3. Summarize how future cardiovascular risk is estimated in primary prevention patients using the Pooled Cohort Equations and PREVENT calculator.
4. Apply the treatment approaches recommended in the most recent ACC-AHA hypertension and dyslipidemia guidelines
5. Illustrate emerging pharmacotherapies for the treatment of hypertension and dyslipidemia
6. Interpret the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia.
7. Create treatment plans that reduce the risk of cardiovascular disease
-
Overcoming Obesity: Update on Current and Future Pharmacotherapy Options
1. Describe appropriate patients who may benefit from obesity pharmacotherapy.
2. Evaluate common obesity medications with potential therapeutic uses as well as common and severe adverse reactions.
3. Identify potential future obesity medication therapies that may offer advantages over current FDA-approved agents.
Drug Interactions:
4. Identify common drug interaction mechanisms including cytochrome P450 enzymes.
5. Identify relevant clinical drug interactions for common medications.
6. Delineate assessment and management strategies for common interactions.
Obesity and Drug Interactions Jeopardy
7: Identify key laboratory values and parameters for monitoring drug therapy.
8. Describe key characteristics of common drug therapies.
9 Identify clinical pearls from various pharmacotherapy therapies.
-
New Drug Update:
1. Describe new drugs approved in the last 12-18 months that have potential to impact clinical practice.
2. Discuss clinical and practical pearls of each new agent where applicable compared to standard therapies.
3. Evaluate each agent's efficacy and safety data to best determine role in therapy.
Review of Current Osteoporosis Treatments:
4. Differentiate pharmacotherapy options for the management of osteoporosis.
5. Apply current osteoporosis treatment guidelines to develop individualized treatment plans.
6. Identify strategies to optimize long-term clinical and safety outcomes.
New Drug, Osteoporosis Jeopardy
7: Identify key laboratory values and parameters for monitoring drug therapy.
8. Describe key characteristics of common drug therapies.
9 Identify clinical pearls from various pharmacotherapy therapies.
Speaker Kudos
Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Professor Associate Dean for Clinical Affairs, Ambulatory Care Pharmacy, Cardiovascular Risk Reduction Department of Clinical Pharmacy Secondary Appointment - Department of Family Medicine, School of Medicine
Dr. Christopher M. Bland | Pharm.D., FCCP
Clinical and Administrative Pharmacy, SavannahAlbert W. Jowdy Professor in Pharmacy CareCo-founder of Southeastern Research Group Endeavor (SERGE45) and TeachMePharm
More …
“Objectives were met and included information that I can absolutely apply in practice. I work in a clinic with a weight loss program, so the more expertise I have in this area, the more valuable I can be to the patients and the care team as a whole. Dr. Bland is an excellent speaker! He presents the material in an engaging and digestible way, encourages participation, and offers insights from his own practice as well. The jeopardy knowledge check at the end was great! Thanks ULS!
clearly stated, was interesting way to achieving the objectives.
”
“The objectives were clear and relevant. The session provided a good understanding of the relationship between their risk factors, potential complications, and the importance of lifestyle modifications and proper management. I feel the objectives were successfully met.”
Accreditation Information
PHARMACISTS: University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for all pharmacists.
University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Pharmacy.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
NURSE PRACTITIONERS American Nurses Credentialing Center (ANCC) and National Certification Corporation (NCC) accept ACPE and AAFP credit. University Learning Systems courses fulfill the pharmacology requirements for ANCC Category 1 Continuing Education Hours for certification renewal.
American Association of Nurse Practitioners (AANP) accepts AAFP/ AMA PRA Category 1™.
NURSESUniversity Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357: Approved these Boards of Nursing: Arkansas, Florida, District of Columbia, Georgia, Kentucky, New Mexico, North Dakota, South Carolina, West VirginiaThe same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.
PHYSICIANS/ PHYSICIAN ASSISTANTS: The AAFP has reviewed Therapeutic Update 2026 and deemed it acceptable for up to 15.00 Live AAFP Prescribed credit(s). Term of Approval is from 04/28/2026 to 12/31/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA). American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program. University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Medicine.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval
See ULS Accredation Statements for more details.